239
Views
22
CrossRef citations to date
0
Altmetric
Reviews

Drug resistance-related microRNAs in esophageal cancer

, MD PhD, , MD, , MD, , MD PhD, , MD, , MD PhD & , MD PhD show all
Pages 1487-1494 | Published online: 25 Jul 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Wanli Yang, Jiaojiao Ma, Wei Zhou, Xin Zhou, Bo Cao, Hongwei Zhang, Qingchuan Zhao, Daiming Fan & Liu Hong. (2017) Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer. Expert Review of Gastroenterology & Hepatology 11:12, pages 1151-1163.
Read now
Wanli Yang, Jiaojiao Ma, Wei Zhou, Bo Cao, Xin Zhou, Zhiping Yang, Hongwei Zhang, Qingchuan Zhao, Daiming Fan & Liu Hong. (2017) Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer. Expert Opinion on Therapeutic Targets 21:11, pages 1063-1075.
Read now
Liu Hong, Yu Han, Hongwei Zhang & Daiming Fan. (2015) Prognostic markers in esophageal cancer: from basic research to clinical use. Expert Review of Gastroenterology & Hepatology 9:7, pages 887-889.
Read now
Liu Hong, Yu Han, Jianjun Yang, Hongwei Zhang, Qingchuan Zhao, Kaichun Wu & Daiming Fan. (2014) MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance. Expert Opinion on Biological Therapy 14:8, pages 1103-1111.
Read now
Liu Hong, Yu Han, Hongwei Zhang, Qingchuan Zhao, Kaichun Wu & Daiming Fan. (2014) Prognosis-related microRNAs in esophageal cancer. Expert Opinion on Biological Therapy 14:4, pages 483-489.
Read now
Liu Hong, Yu Han, Hongwei Zhang, Qingchuan Zhao, Kaichun Wu & Daiming Fan. (2014) Drug resistance-related miRNAs in hepatocellular cancer. Expert Review of Gastroenterology & Hepatology 8:3, pages 283-288.
Read now
Liu Hong, Yu Han, Yujie Zhang, Hongwei Zhang, Qingchuan Zhao, Kaichun Wu & Daiming Fan. (2013) MicroRNA-21: a therapeutic target for reversing drug resistance in cancer. Expert Opinion on Therapeutic Targets 17:9, pages 1073-1080.
Read now

Articles from other publishers (15)

Paula Cabello, Sandra Torres-Ruiz, Anna Adam-Artigues, Jaume Forés-Martos, María Teresa Martínez, Cristina Hernando, Sandra Zazo, Juan Madoz-Gúrpide, Ana Rovira, Octavio Burgués, Federico Rojo, Joan Albanell, Ana Lluch, Begoña Bermejo, Juan Miguel Cejalvo & Pilar Eroles. (2023) miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer. Cancers 15:7, pages 2138.
Crossref
Jiajin Wan, Chunling Niu, Baiyan Wang, Qianqian Han, Yulon Chen, Shuying Feng & Lianhe Yang. (2021) Human esophageal fibroblast-derived exosomal miR-21 reduced the cisplatin sensitivity to esophageal carcinoma EC9706 cells. Brazilian Journal of Medical and Biological Research 54:10.
Crossref
Liang Liu, Yanhua Zuo, Yan Xu, Zongfang Zhang, Ying Li & Jie Pang. (2019) MiR-613 inhibits proliferation and invasion and induces apoptosis of rheumatoid arthritis synovial fibroblasts by direct down-regulation of DKK1. Cellular & Molecular Biology Letters 24:1.
Crossref
Penggao Dai, Yancheng He, Guosong Luo, Jiaqi Deng, Nan Jiang, Tingting Fang, Yujuan Li & Ying Cheng. (2019) Screening candidate microRNA‐mRNA network for predicting the response to chemoresistance in osteosarcoma by bioinformatics analysis. Journal of Cellular Biochemistry 120:10, pages 16798-16810.
Crossref
Christiane Matuszcak, Kirsten Lindner, Ann-Kathrin Eichelmann, Damian J. Hussey, Jörg Haier & Richard Hummel. (2018) microRNAs: Key regulators of chemotherapy response and metastatic potential via complex control of target pathways in esophageal adenocarcinoma. Surgical Oncology 27:3, pages 392-401.
Crossref
Moein Amin, Farhadul Islam, Vinod Gopalan & Alfred K. Lam. 2018. Esophageal Adenocarcinoma. Esophageal Adenocarcinoma 257 268 .
Tao Jiang, Pengfei Dong, Long Li, Xiao Ma, Pei Xu, He Zhu, Yanqiu Wang, Baotong Yang, Kuangge Liu, Jinwei Liu, Juan Xue, Runzhe Lv, Panke Su, Guoqiang Kong, Yongchao Chang, Chonggao Zhao & Lidong Wang. (2017) MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells. Oncology Reports.
Crossref
Xiaoyan Xu, Haiyan Chen, Qin Zhang, Jin Xu, Qing Shi & Meimei Wang. (2017) MiR-650 inhibits proliferation, migration and invasion of rheumatoid arthritis synovial fibroblasts by targeting AKT2. Biomedicine & Pharmacotherapy 88, pages 535-541.
Crossref
Michelle J. Nyhan, Tracey R. O’Donovan, Antonius W. M. Boersma, Erik A. C. Wiemer & Sharon L. McKenna. (2016) MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cells. BMC Cancer 16:1.
Crossref
Ying-ying Jin, Qing-juan Chen, Kun Xu, Hong-tao Ren, Xing Bao, Yi-nan Ma, Yang Wei & Hong bing Ma. (2016) Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN. Molecular and Cellular Biochemistry 422:1-2, pages 161-170.
Crossref
Maryam Hemmatzadeh, Hamed Mohammadi, Mohammad Karimi, Mohammad Hossein Musavishenas & Behzad Baradaran. (2016) Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer. Biomedicine & Pharmacotherapy 82, pages 509-519.
Crossref
Zhe Jin, Xiaojing Zhang & Xinmin Fan. 2015. Epigenetic Cancer Therapy. Epigenetic Cancer Therapy 351 372 .
Heath D. Skinner, Jeffrey H. Lee, Manoop S. Bhutani, Brian Weston, Wayne Hofstetter, Ritsuko Komaki, Hironori Shiozaki, Roopma Wadhwa, Kazuki Sudo, Elena Elimova, Shumei Song, Yuanqing Ye, Maosheng Huang, Jaffer Ajani & Xifeng Wu. (2014) A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer 120:23, pages 3635-3641.
Crossref
Liang Chang, Fengjie Guo, Yudong Wang, Yalei Lv, Bingjie Huo, Long Wang & Wei Liu. (2013) MicroRNA-200c Regulates the Sensitivity of Chemotherapy of Gastric Cancer SGC7901/DDP Cells by Directly Targeting RhoE. Pathology & Oncology Research 20:1, pages 93-98.
Crossref
J. Wang, H. Huang, C. Wang, X. Liu, F. Hu & M. Liu. (2013) MicroRNA-375 sensitizes tumour necrosis factor-alpha (TNF-α)-induced apoptosis in head and neck squamous cell carcinoma in vitro. International Journal of Oral and Maxillofacial Surgery 42:8, pages 949-955.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.